Literature DB >> 183950

Nuclear poly(A) polymerase from rat liver and a hepatoma. Comparison of properties, molecular weights and amino acid compositions.

K M Rose, S T Jacob.   

Abstract

Poly(A) polymerase was extracted from isolated nuclei of rat liver and a rapidly growing solid tumor (Morris hepatoma 3924A). The enzyme from each tissue was purified by successive chromatography on DEAE-Sephadex, phosphoecllulose, hydroxyapatite and QAE-Sephadex. Purified enzyme from both liver and tumor was essentially homogeneous as judged by polyacrylamide gel electrophoresis. Under nondenaturing conditions, enzyme activity corresponded to visible protein and, upon denaturation, a single polypeptide was detected. The enzymes had absolute requirements for Mn2+ as the divalent ion, ATP as the substrate and an oligonucleotide or polynucleotide as the primer. Both enzymes were inhibited by sodium pyrophosphate, N-ethylmaleimide, Rose Bengal, cordycepin 5'-triphosphate and several rifamycin derivatives. The reactions were unaffected by potassium phosphate, alpha-amanitin and pancreatic ribonuclease. However, the liver and hepatoma enzymes differed from each other with respect to apparent Km, primer saturation levels and sensitivity to pH changes. The most striking differences between the enzymes were in their calculated molecular weights (liver, 48000; hepatoma, 60000) and amino acid compositions. Finally, the level of the hepatoma enzyme relative to that of the liver enzyme was at least 1.5-fold higher when expressed per mg DNA.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 183950     DOI: 10.1111/j.1432-1033.1976.tb10626.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  14 in total

1.  Potential role of poly(A) polymerase in the assembly of polyadenylation-specific RNP complexes.

Authors:  M P Terns; S T Jacob
Journal:  Nucleic Acids Res       Date:  1991-01-25       Impact factor: 16.971

2.  Antibodies against nuclear poly(A) polymerases in rheumatic autoimmune diseases.

Authors:  D A Stetler; M Reichlin; C M Berlin; S T Jacob
Journal:  J Clin Immunol       Date:  1987-01       Impact factor: 8.317

3.  Increase in the levels of activity of polyadenylic acid-metabolizing enzymes following phytohaemagglutinin stimulation of human lymphocytes.

Authors:  N C Courtis; T T Trangas; C M Tsiapalis
Journal:  Mol Cell Biochem       Date:  1987-05       Impact factor: 3.396

4.  Hydrolysis of poly (A) to adenine nucleotides by purified poly (A) polymerase.

Authors:  A K Abraham; S T Jacob
Journal:  Proc Natl Acad Sci U S A       Date:  1978-05       Impact factor: 11.205

5.  Identification and functional characterization of neo-poly(A) polymerase, an RNA processing enzyme overexpressed in human tumors.

Authors:  S L Topalian; S Kaneko; M I Gonzales; G L Bond; Y Ward; J L Manley
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

6.  HnRNP particles.

Authors:  W J van Venrooij; D B Janssen
Journal:  Mol Biol Rep       Date:  1978-02-28       Impact factor: 2.316

7.  Biochemical and immunological identification and enrichment of poly(A) polymerase from human thymus.

Authors:  C Kyriakopoulou; C M Tsiapalis; M Havredaki
Journal:  Mol Cell Biochem       Date:  1996-01-12       Impact factor: 3.396

8.  Multiple forms of poly(A) polymerases in human cells.

Authors:  A C Thuresson; J Aström; A Aström; K O Grönvik; A Virtanen
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-01       Impact factor: 11.205

9.  Immunization of rabbits with purified RNA polymerase I induces a distinct population of antibodies against nucleic acids as well as anti-RNA polymerase I antibodies, both characteristic of systemic lupus erythematosus.

Authors:  D A Stetler; S T Jacob
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

10.  Antibodies to distinct polypeptides of RNA polymerase I in sera from patients with rheumatic autoimmune disease.

Authors:  D A Stetler; K M Rose; M E Wenger; C M Berlin; S T Jacob
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.